TK.007: A Novel, Codon-Optimized HSVtk(A168H) Mutant for Suicide Gene TherapyPREUSS, Ellen; TRESCHOW, Alexandra; FEHSE, Boris et al.Human gene therapy. 2010, Vol 21, Num 8, pp 929-941, issn 1043-0342, 13 p.Article

Comparison of Different Suicide-Gene Strategies for the Safety Improvement of Genetically Manipulated T CellsMARIN, Virna; CRIBIOLI, Elisabetta; PHILIP, Brian et al.Human gene therapy. Part B. Methods (Print). 2012, Vol 23, Num 6, pp 376-386, issn 1946-6536, 11 p.Article

Tumor-specific transcriptional targeting of suicide gene therapyQIAO, J; DOUBROVIN, M; WOOL, S. L. C et al.Gene therapy (Basingstoke). 2002, Vol 9, Num 3, pp 168-175, issn 0969-7128Article

The completed suicide as interplay of genes and environmentBALAZIC, J; MARUSIC, A.Forensic science international. 2005, Vol 147, pp S1-S3, issn 0379-0738, SUPConference Paper

Tumour cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapyWORTHINGTON, J; ROBSON, T; O'KEEFE, M et al.Gene therapy (Basingstoke). 2002, Vol 9, Num 4, pp 263-269, issn 0969-7128Article

The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies. CommentaryTIBERGHIEN, Pierre; TRAVERSARI, Catia; MARKTEL, Sarah et al.Blood. 2007, Vol 109, Num 11, issn 0006-4971, 4595, 4708-4715 [9 p.]Article

Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccineWENHONG REN; STRUBE, Randy; XIAOQING ZHANG et al.Cancer research (Baltimore). 2004, Vol 64, Num 18, pp 6645-6651, issn 0008-5472, 7 p.Article

Efficacy of recombinant adenovirus-mediated double suicide gene therapy in human keloid fibroblastsXU, B; LIU, Z. Z; ZHU, G. Y et al.Clinical and experimental dermatology (Print). 2008, Vol 33, Num 3, pp 322-328, issn 0307-6938, 7 p.Article

Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible Grp78 promoter resulting in eradication of sizable human tumorsDEZHENG DONG; DUBEAU, Louis; GAMBHIR, Sanjiv S et al.Human gene therapy. 2004, Vol 15, Num 6, pp 553-561, issn 1043-0342, 9 p.Article

Provision of positive and negative selections in retroviral vectors containing the cytosine deaminase geneSHIAU, A.-L; YANG, H.-M; WU, P et al.Gene therapy (Basingstoke). 1998, Vol 5, Num 11, pp 1571-1574, issn 0969-7128Article

A stochastic killing system for biological containment of Escherichia coliKLEMM, P; JENSEN, L. B; MOLIN, S et al.Applied and environmental microbiology (Print). 1995, Vol 61, Num 2, pp 481-486, issn 0099-2240Article

Gene transfer in tumor therapyFORNI, G; PARMIANI, G; GUARINI, A et al.Annals of oncology. 1994, Vol 5, Num 9, pp 789-794, issn 0923-7534Article

Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes. CommentaryDUDLEY, Mark E; QUINTARELLI, Concetta; DOTTI, Gianpietro et al.Blood. 2007, Vol 110, Num 8, issn 0006-4971, 2781-2782, 2793-2802 [12 p.]Article

Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatmentISHII-MORITA, H; AGBARIA, R; MULLEN, C. A et al.Gene therapy (Basingstoke). 1997, Vol 4, Num 3, pp 244-251, issn 0969-7128Article

Recent advances in treatment of medullary thyroid carcinomaVEZZOSI, D; BENNET, A; CARON, P et al.Annales d'endocrinologie. 2007, Vol 68, Num 2-3, pp 147-153, issn 0003-4266, 7 p.Article

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safetyHOYOS, V; SAVOLDO, B; QUINTARELLI, C et al.Leukemia. 2010, Vol 24, Num 6, pp 1160-1170, issn 0887-6924, 11 p.Article

Controlled propagation of replication-competent Sindbis viral vector using suicide gene strategyTSENG, J.-C; DANIELS, G; MERUELO, D et al.Gene therapy (Basingstoke). 2009, Vol 16, Num 2, pp 291-296, issn 0969-7128, 6 p.Article

Fusion of HSV-1 VP22 to a bifunctional chimeric SuperCD suicide gene compensates for low suicide gene transduction efficienciesLEMKEN, Marie-Luise; GRAEPLER, Florian; WOLF, Claudia et al.International journal of oncology. 2007, Vol 30, Num 5, pp 1153-1161, issn 1019-6439, 9 p.Article

The influence of four serotonin-related genes on decision-making in suicide attemptersJOLLANT, Fabrice; BURESI, Catherine; GUILLAUME, Sébastien et al.American journal of medical genetics. Part B, Neuropsychiatric genetics. 2007, Vol 144, Num 5, pp 615-624, issn 1552-4841, 10 p.Article

Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host diseaseSERAFINI, M; MANGANINI, M; BORLERI, G et al.Human gene therapy. 2004, Vol 15, Num 1, pp 63-76, issn 1043-0342, 14 p.Article

Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host diseaseMAURY, S; LITVINOVA, E; BOYER, O et al.Gene therapy (Basingstoke). 2002, Vol 9, Num 3, pp 201-207, issn 0969-7128Article

Use of suicide gene-expressing donor T-cells to control alloreactivity after haematopoietic stem cell transplantationTIBERGHIEN, P.Journal of internal medicine. 2001, Vol 249, Num 4, pp 369-377, issn 0954-6820Conference Paper

Therapeutic genes for cancer gene therapyWALTHER, W; STEIN, U.Molecular biotechnology. 1999, Vol 13, Num 1, pp 21-28, issn 1073-6085Article

The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communicationTOURAINE, R. L; ISHII-MORITA, H; RAMSEY, W. J et al.Gene therapy (Basingstoke). 1998, Vol 5, Num 12, pp 1705-1711, issn 0969-7128Article

The promise and reality of cancer gene therapyHALL, S. J; CHEN, S.-H; WOO, S. L. C et al.American journal of human genetics. 1997, Vol 61, Num 4, pp 785-789, issn 0002-9297Article